What happens when small quantities of dead or inactive forms of a pathogen are introduced into the body during vaccination?
What happens when small quantities of dead or inactive forms of a pathogen are introduced into the body during vaccination?
Answer
When small quantities of dead or inactive forms of a pathogen are introduced into the body during vaccination, several important immunological processes occur, leading to the development of immunity without causing disease. Here’s a detailed overview of what happens:
Introduction of Inactivated Pathogens
Inactivated Vaccines
Inactivated vaccines consist of pathogens that have been killed or rendered non-infectious through methods such as heat, chemicals (like formaldehyde), or radiation. While these pathogens can no longer replicate or cause disease, they retain enough structural integrity to be recognized by the immune system.
Immune Response Activation
Primary Immune Response
Upon vaccination, the body’s immune system recognizes the inactivated pathogen as a foreign invader. This triggers a primary immune response, which includes:
- Antigen Recognition: Immune cells, particularly dendritic cells, identify the inactivated pathogen’s antigens.
- Activation of B Cells: B cells are stimulated to produce antibodies specific to the pathogen. These antibodies are crucial for neutralizing the pathogen if encountered in the future.
- T Cell Activation: Helper T cells assist in orchestrating the immune response, while cytotoxic T cells may also be activated to help eliminate infected cells if necessary.
Memory Cell Formation
Following the initial response, some B and T cells differentiate into memory cells. These memory cells persist in the body and enable a faster and more robust response upon subsequent exposures to the same pathogen.
Safety and Stability
Non-Infectious Nature
Since inactivated vaccines contain dead pathogens, there is no risk of causing disease in vaccinated individuals. This makes them particularly safe for populations with weakened immune systems. Additionally, inactivated vaccines are generally more stable than live vaccines, allowing for easier storage and transport.
Limitations
Weaker Immune Response
Inactivated vaccines typically elicit a weaker immune response compared to live attenuated vaccines. As a result, they often require multiple doses or booster shots to maintain adequate immunity over time. The need for adjuvants—substances that enhance the body’s immune response to the vaccine—may also arise to improve efficacy
Sourav
